This site is intended for Healthcare Professionals only.

Class 2 recall for Olopatadine eye drops


Share post:

The Medicines and Healthcare products Regulatory Agency has issued a class 2 medicines recall notice for Olopatadine USV 1mg/ml eye drops.

Specific batches of this product are being recalled by USV UK Limited as a precautionary measure due to the identification of out of specification results for impurities during routine stability testing.

USV UK Limited are recalling the affected batches as a precautionary measure due to out of specification results for impurities during routine stability testing.

Batch Number Expiry Date Pack Size First Distributed
35000201 07/2023 5ml 14 July 2021
35000202 07/2023 5ml 27 July 2021
35000203 07/2023 5ml 5 August 2021
35000204 07/2023 5ml 29 November 2021
35000206 07/2023 5ml 23 July 2021


While the company’s investigation is on-going, community pharmacy contractors should stop supplying the specified batches immediately, quarantine all remaining stock, and return it to their supplier using their supplier’s approved process.



Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

Whooping cough outbreak in England: 9 infant deaths in six months

A combination of factors, including a decline in vaccination uptake, is believed to be contributing to the rise...

Multiple sclerosis: England approves new jab that cuts hospital treatment time by 90%

In addition to significantly reducing treatment time for patients, the new multiple sclerosis injection could also save time...

NHS GP Patient survey2024 highlights positive pharmacy service experiences

According to the NHS survey, 49.7 per cent patients contacted a pharmacy via phone, practice websites (47.9 per...

NHS performance data highlights urgent need for government action

Commenting on the publication of the NHS monthly performance statistics Tim Gardner, Assistant Director of Policy at the...